Ionis Pharmaceuticals Inc
(STU:ISI)
€
34.62
0.13 (0.38%)
Market Cap: 5.44 Bil
Enterprise Value: 4.45 Bil
PE Ratio: 0
PB Ratio: 8.55
GF Score: 59/100 Ionis Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2022 / 06:15PM GMT
Release Date Price:
€45.97
(-0.16%)
Andrew Francis Galler
Morgan Stanley, Research Division - Equity Analyst
Good afternoon, everyone. I'm Andrew Galler, one of the biotech analysts here at Morgan Stanley. And I'm joined today by Brett Monia, CEO of Ionis Pharmaceuticals. So to start off, I'll read our disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Questions & Answers
Andrew Francis Galler
Morgan Stanley, Research Division - Equity Analyst
So Brett, I wanted to kick it off just, you've been in this role a little over 30 months now. So I want to understand how your vision for Ionis has evolved in your opinion to the company and the direction forward?
Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director
Thank you, Andrew, and thanks for the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot